Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41 (Q81786171)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 March 2005

Language	Label	Description	Also known as
English	Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41	scientific article published on 30 March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Steven G Reed

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

object named as

Ian M Orme

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Yasir A W Skeiky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mark R Alderson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Pamela J Ovendale

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Yves Lobet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Wilfried Dalemans

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Antonio Campos-Neto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

30 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

3937-3945

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Global challenge of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

BCG: the challenge continues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

DNA vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

The immunogenicity of single and combination DNA vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Functional Characterization of Class Ia- and Non-Class Ia-RestrictedChlamydia-Reactive CD8+ T Cell Responses in Humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Efficient screening of retroviral cDNA expression libraries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Immunization of mice with mycobacterial culture filtrate proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Importance of thymus-derived lymphocytes in cell-mediated immunity to infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.03.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917115%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81786171&oldid=1775326496"